
Diabifence G 1mg/500mg Tablet
Marketer
Gelmek Healthcare
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Diabifence G 1mg/500mg Tablet
GlycemiaGuard 1mg/500mg tablets are classified as anti-diabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer GlycemiaGuard with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled glucose levels; abrupt cessation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb damage. This medication is part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available fast-acting glucose (e.g., sugary foods, juice) are essential preventative measures. Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease before commencing treatment; it may be unsuitable. Pregnant or lactating individuals should seek medical advice prior to use. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, will be recommended by your doctor.
Primary Ingredients of Diabifence G 1mg/500mg Tablet
No text provided. Please provide the text you want me to rephrase.
Uses of Diabifence G 1mg/500mg Tablet
Managing Type 2 Diabetes
Major Benefits of Diabifence G 1mg/500mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the Diabifence G 1mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Diabifence G 1mg/500mg Tablet:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Diabifence G 1mg/500mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Diabifence G 1mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.
How Diabifence G 1mg/500mg Tablet works:
Diabifence G, a 1mg/500mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Diabifence G 1mg/500mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Diabifence G 1mg/500mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Lactation and Diabifence G 1mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Diabifence G 1mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Diabifence G 1mg/500mg tablets. Physician consultation is necessary. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Individuals with liver impairment should use Diabifence G 1mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation with a low dose is typical; however, its use is contraindicated in cases of severe liver dysfunction.
What if you forget to take Diabifence G 1mg/500mg Tablet :
Should you forget to take your Diabifence G 1mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Diabifence G 1mg/500mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
